ABCA7 and Alzheimer disease: It should be noted that even in the absence of the AD transgene expression, Abca7−/− null mice were found to exhibit an age-dependent increase in the levels of the pathogenic (endogenous) Aβ42 peptide in the brain; assessed up to 6 months of age [13].